Advertisement
Review Article| Volume 103, ISSUE 1, P155-167, February 2023

Quality of Life Issues Following Breast Cancer Treatment

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Surgical Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Cristian A.
        Breast cancer and gynecologic cancer rehabilitation.
        ([Online]. Available:) (Accessed date May 25, 2022)
        • Jiralerspong S.
        • Goodwin P.J.
        Obesity and Breast Cancer Prognosis: Evidence, Challenges, and Opportunities.
        J Clin Oncol. 2016; 34: 4203-4216https://doi.org/10.1200/JCO.2016.68.4480
        • Chlebowski R.T.
        • et al.
        Weight loss and breast cancer incidence in postmenopausal women.
        Cancer. 2019; 125: 205-212
      1. Integrative Medicine: Search About Herbs | Memorial Sloan Kettering Cancer Center.
        (Available at:) (Accessed May 26, 2022)
        • Simapivapan P.
        • Boltong A.
        • Hodge A.
        To what extent is alcohol consumption associated with breast cancer recurrence and second primary breast cancer?: a systematic review.
        Cancer Treat. Rev. 2016; 50: 155-167
        • Coletta A.M.
        • Basen-Engquist K.M.
        • Schmitz K.H.
        Exercise Across the Cancer Care Continuum: Why It Matters, How to Implement It, and Motivating Patients to Move.
        Am Soc Clin Oncol Educ Book. 2022; 42: 1-7
        • Campbell K.L.
        • et al.
        Exercise Recommendation for People With Bone Metastases: Expert Consensus for Health Care Providers and Exercise Professionals.
        JCO Oncol Pract. 2022; 18: e697-e709
      2. Moving Through Cancer,” Moving Through Cancer.
        (Available at:) (Accessed May 26, 2022)
        • Kingsberg S.A.
        • Simon J.A.
        Female Hypoactive Sexual Desire Disorder: A Practical Guide to Causes, Clinical Diagnosis, and Treatment.
        J Womens Health. 2020; 29: 1101-1112
        • Kim L.
        Hypoactive sexual desire disorder: How do you identify it and treat it?.
        Women’s Healthc. 2019; (Available at:) (Accessed July 16, 2022)
        • Dupree B.
        The American Society of Breast Surgeons | ASBrS,” The American Society of Breast Surgeons Fellows Webinars, Surveillance and Survivorship.
        (Accessed May 25, 2022)
        • Gass J.
        • et al.
        Breast Cancer Survivorship: Why, What and When?.
        Ann Surg Oncol. 2016; 23: 3162-3167
        • Fann J.R.
        • et al.
        Major depression after breast cancer: a review of epidemiology and treatment.
        Gen Hosp Psychiatry. 2008; 30: 112-126
        • Hermelink K.
        Chemotherapy and Cognitive Function in Breast Cancer Patients: The So-Called Chemo Brain.
        JNCI Monogr. 2015; 51: 67-69
        • McDonald B.C.
        • Conroy S.K.
        • Ahles T.A.
        • et al.
        Alterations in Brain Activation During Working Memory Processing Associated With Breast Cancer and Treatment: A Prospective Functional Magnetic Resonance Imaging Study.
        J Clin Oncol. 2012; 30: 2500-2508
        • Pomykala K.L.
        • de Ruiter M.B.
        • Deprez S.
        • et al.
        Integrating imaging findings in evaluating the post-chemotherapy brain.
        Brain Imaging Behav. 2013; 7: 436-452
        • Raji M.A.
        • et al.
        Risk of subsequent dementia diagnoses does not vary by types of adjuvant chemotherapy in older women with breast cancer.
        Med Oncol Northwood Lond Engl. 2009; 26: 452-459
        • Bai L.
        • Yu E.
        A narrative review of risk factors and interventions for cancer-related cognitive impairment.
        Ann Transl Med. 2021; 9: 72
        • Bhatnagar B.
        • et al.
        Chemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single-center experience.
        SpringerPlus. 2014; 3: 366
        • Mols F.
        • Beijers T.
        • Vreugdenhil G.
        • et al.
        Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review.
        Support Care Cancer. 2014; 22: 2261-2269
        • Stubblefield M.D.
        • et al.
        NCCN Task Force Report: Management of Neuropathy in Cancer.
        J Natl Compr Cancer Netw J Natl Compr Canc Netw. 2009; 7 (S-1-S-26)https://doi.org/10.6004/jnccn.2009.0078
        • Stubblefield M.D.
        • McNeely M.L.
        • Alfano C.M.
        • et al.
        A prospective surveillance model for physical rehabilitation of women with breast cancer.
        Cancer. 2012; 118: 2250-2260
        • Tofthagen C.
        Patient Perceptions Associated With Chemotherapy-Induced Peripheral Neuropathy.
        Clin J Oncol Nurs. 2010; 14 (E22–E28)
        • Gutiérrez-Gutiérrez G.
        • Sereno M.
        • Miralles A.
        • et al.
        Chemotherapy-induced peripheral neuropathy: clinical features, diagnosis, prevention and treatment strategies.
        Clin Transl Oncol. 2010; 12: 81-91
        • Zwart W.
        • Terra H.
        • Linn S.C.
        • et al.
        Cognitive effects of endocrine therapy for breast cancer: keep calm and carry on?.
        Nat Rev Clin Oncol. 2015; 12 (Art. no. 10)https://doi.org/10.1038/nrclinonc.2015.124
        • Peddie N.
        • Agnew S.
        • Crawford M.
        • et al.
        The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: A qualitative systematic review and thematic synthesis.
        The Breast. 2021; 58: 147-159
        • Franzoi M.A.
        • et al.
        Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer.
        Lancet Oncol. 2021; 22 (e303–e313)https://doi.org/10.1016/S1470-2045(20)30666-5
        • Kagan R.
        • Kellogg-Spadt S.
        • Parish S.J.
        Practical Treatment Considerations in the Management of Genitourinary Syndrome of Menopause.
        Drugs Aging. 2019; 36: 897-908
        • Andersen K.G.
        • Kehlet H.
        Persistent Pain After Breast Cancer Treatment: A Critical Review of Risk Factors and Strategies for Prevention.
        J Pain. 2011; 12: 725-746
        • Larsson I.M.
        • Ahm Sørensen J.
        • Bille C.
        The Post-mastectomy Pain Syndrome—A Systematic Review of the Treatment Modalities.
        Breast J. 2017; 23: 338-343
        • Gärtner R.
        • Jensen M.-B.
        • Nielsen J.
        • et al.
        Prevalence of and Factors Associated With Persistent Pain Following Breast Cancer Surgery.
        JAMA. 2009; 302: 1985-1992
        • Chhabra A.
        • Roy Chowdhury A.
        • Prabhakar H.
        • et al.
        Paravertebral anaesthesia with or without sedation versus general anaesthesia for women undergoing breast cancer surgery.
        Cochrane Database Syst Rev. 2021; 2https://doi.org/10.1002/14651858.CD012968.pub2
        • Pappalardo M.
        • Starnoni M.
        • Franceschini G.
        • et al.
        Breast Cancer-Related Lymphedema: Recent Updates on Diagnosis, Severity and Available Treatments.
        J Pers Med. 2021; 11: 402https://doi.org/10.3390/jpm11050402
        • McLaughlin S.
        The Valuable Ounce: Surgical and Radiation Oncology Considerations for Lymphedema Prevention,” Lymphedema- Diagnosis and management.
        (Available at:) (Accessed May 30, 2022)
        • Fleissig A.
        • et al.
        Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer.
        Breast Cancer Res Treat. 2006; 95: 279-293
        • Grada A.A.
        • Phillips T.J.
        Lymphedema: Pathophysiology and clinical manifestations.
        J Am Acad Dermatol. 2017; 77: 1009-1020
        • Armer J.M.
        • et al.
        Lymphedema symptoms and limb measurement changes in breast cancer survivors treated with neoadjuvant chemotherapy and axillary dissection: results of American College of Surgeons Oncology Group (ACOSOG) Z1071 (Alliance) substudy.
        Support Care Cancer. 2019; 27: 495-503
        • McDuff S.G.R.
        • et al.
        Timing of Lymphedema After Treatment for Breast Cancer: When Are Patients Most At Risk?.
        Int J Radiat Oncol Biol Phys. 2019; 103: 62-70
        • Gillespie T.C.
        • Sayegh H.E.
        • Brunelle C.L.
        • et al.
        Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments.
        Gland Surg. 2018; 7: 379-403
        • Eaton L.H.
        • Narkthong N.
        • Hulett J.M.
        Psychosocial Issues Associated with Breast Cancer-Related Lymphedema: a Literature Review.
        Curr Breast Cancer Rep. 2020; 12: 216-224
        • Asdourian M.S.
        • et al.
        Association Between Precautionary Behaviors and Breast Cancer–Related Lymphedema in Patients Undergoing Bilateral Surgery.
        J Clin Oncol. 2017; 35: 3934-3941
        • McLaughlin S.A.
        • et al.
        Trends in Risk Reduction Practices for the Prevention of Lymphedema in the First 12 Months after Breast Cancer Surgery.
        J Am Coll Surg. 2013; 216: 380-389
        • Kwan M.L.
        • Cohn J.C.
        • Armer J.M.
        • et al.
        Exercise in patients with lymphedema: a systematic review of the contemporary literature.
        J Cancer Surviv. 2011; 5: 320-336
        • Schmitz K.H.
        • et al.
        Effect of Home-Based Exercise and Weight Loss Programs on Breast Cancer–Related Lymphedema Outcomes Among Overweight Breast Cancer Survivors: The WISER Survivor Randomized Clinical Trial.
        JAMA Oncol. 2019; 5: 1605-1613
        • Gasteratos K.
        • Morsi-Yeroyannis A.
        • Vlachopoulos N.C.
        • et al.
        Microsurgical techniques in the treatment of breast cancer-related lymphedema: a systematic review of efficacy and patient outcomes.
        Breast Cancer Tokyo Jpn. 2021; 28: 1002-1015
        • Basta M.N.
        • et al.
        Complicated breast cancer–related lymphedema: evaluating health care resource utilization and associated costs of management.
        Am J Surg. 2016; 211: 133-141
        • Brahma B.
        • Yamamoto T.
        Breast cancer treatment-related lymphedema (BCRL): An overview of the literature and updates in microsurgery reconstructions.
        Eur J Surg Oncol. 2019; 45: 1138-1145
        • Senkus-Konefka E.
        • Jassem J.
        Complications of breast-cancer radiotherapy.
        Clin Oncol R Coll Radiol G B. 2006; 18: 229-235
        • Ducray J.
        • et al.
        [Radiation-induced bronchiolitis obliterans with organizing pneumonia].
        Cancer Radiother J Soc Francaise Radiother Oncol. 2017; 21: 148-154
        • Hanania A.N.
        • Mainwaring W.
        • Ghebre Y.T.
        • et al.
        Radiation-Induced Lung Injury: Assessment and Management.
        Chest. 2019; 156: 150-162
        • Taylor C.W.
        • Kirby A.M.
        Cardiac Side-effects From Breast Cancer Radiotherapy.
        Clin Oncol R Coll Radiol G B. 2015; 27: 621-629
        • Caron J.
        • Nohria A.
        Cardiac Toxicity from Breast Cancer Treatment: Can We Avoid This?.
        Curr Oncol Rep. 2018; 20: 61
        • Hille-Betz U.
        • et al.
        Late radiation side effects, cosmetic outcomes and pain in breast cancer patients after breast-conserving surgery and three-dimensional conformal radiotherapy : Risk-modifying factors.
        Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al. 2016; 192: 8-16
        • Ho A.Y.
        • Hu Z.I.
        • Mehrara B.J.
        • et al.
        Radiotherapy in the setting of breast reconstruction: types, techniques, and timing.
        Lancet Oncol. 2017; 18: e742-e753
        • Batenburg M.C.T.
        • et al.
        The impact of hyperbaric oxygen therapy on late radiation toxicity and quality of life in breast cancer patients.
        Breast Cancer Res Treat. 2021; 189: 425-433